A new approach to the asymmetric synthesis of pentadeca-1,3,5,7,9,11,13,15-octols and their derivatives is presented. It is based on the Sharpless asymmetric dihydroxylation (AD) of 4,4'-methylene[(1R,1'S,6R,6'S)-6-acetoxycyclohept-3-en-1-yl]bis(4-methoxybenzoate) (9), derived from a double [3+4] cycloaddition of the 1,1,3-trichloro-2-oxyallyl cation with 2,2'-methylenedifuran (1). The diol (-)-10, obtained in 98.4% ee from 9 with "AD-mix-beta(5x), was oxidised into (2R and 2S,4S,6R)-tetrahydro-2-hydroxy-6-((4S,6S)-(6-hydroxy-4-[(4-methoxybenzoyl)oxy]cyclohept-1-en-1-yl)-2-oxopropyl)-2H-pyran-4-yl 4-methoxybenzoates ((-)-18). By the combinations of Evans' anti and Nasaraka's syn reductions of aldol (-)-18 with the double Mitsunobu reaction, 16 diastereomeric pentadeca-1,3,5,7,9,11,13,15-octols and analogues can be obtained, in principle, with high enantio- and diastereoselectivities.
A great variety of natural products of biological interest includes polyketides (1,3-polyoxo, 1,3-polyols, aldols). 1 Several approaches for their synthesis have been proposed. 2,3 Inspired by the work of Lautens 4 and Hoffmann and co-workers, 5 who have converted 8-oxabicyclo[3.2.1]oct-6-en-3-one into 7-carbon-1,3-polyols and analogues, 6 and by that of Kaku et al.,7 who have transformed cyclohept-3-ene-1,6-diol into 1,3-polyols, we have proposed a new, noniterative asymmetric synthesis of longchain 1,3-polyols starting from the now readily available 2,2′-methylenedifuran (1). 8 The method imployed the double [3+4]-cycloaddition of the 1,1,3-trichloro-2-oxyallyl cation to 1. After reductive workup, a 45:55 mixture of meso-2 and (()-threo-2 was obtained in 55% yield and separated by fractional crystallizations. The meso compound was converted into meso-3, which was desymmetrized into diol (-)-4 by means of the Sharpless asymmetric dihydroxylation. 9 Further transformations imploying the combinations of Evans' anti 10 and Nasaraka's syn 11 aldol reductions with Mitsunobu reaction 12 allow to prepare, in principle, 16 diastereomeric pentadecane-1, 3,5,7,9,11,13,15-octols (e.g., (-)-5) and analogues (Scheme 1). If the syn relationship between the 4-methoxybenzoates at C-3 and C-13 (atom numbering of (-)-5) could be changed into an anti relative configuration, all possible stereomeric pentadecane-1,3,5,7,9,11,13,15-octols could be reached in both enantiomeric forms. We report here a solution to that problem.As already described, 8 diol (-)-4 was converted (Scheme 2) into tetrol (-)-6 in 75% overall yield. Treatment of (-)-6 with (MeO) 2 CMe 2 in acetone under acidic conditions (pyridinium paratoluenesulfonate) gave acetonide (-)-7 in 92% yield. Heating (-)-7 in acetonitrile in the presence of 12 equiv of DBU (1,8-diazabicyclo[5.4.0]undec-7-ene) induced the isomerization of (-)-7 into the primary paramethoxybenzoate (-)-8. Equilibrium ([(-)-8]/[(-)-7] ) 3.0) was reached after 4 h at 80 °C, and (-)-8 could be isolated in 70% yield (Scheme 2). This result can be interpreted in terms of acyl group migration from the C-3 to the C-1 position (atom numbering of (-)-5; IUPAC numbering: 2′′′,4′′′, see (-)-8), the primary ester (-)-8 being more stable than (-)-7 for steric reasons. Also for steric reasons, the intramolecular migration of the paramethoxybenzoyl group from the 1-oxy position to the 6-hydroxy group of the cycloheptenol moiety is forbidden. Attempts to displace the acyclic secondary alcohol at C-3 (atom numbering of (-)-5; IUPAC: 2′′′) using the Mitsunobu reaction ((EtOOC) 2 N 2 , PPh 3 , 4-NO 2 C 6 H 4 COOH) 12 were not met with success. They led to complex mixtures. Selective sulfonylation of the acyclic alcohol at C-3 (IUPAC: 2′′′) with CH 3 SO 2 Cl and p-TsCl (pyridine, Et 3 N) also led to intractable mixtures.Selective methanolysis of the acyclic paramethoxybenzoate at C-3 (IUPAC: 6′) was possible on treating (-)-7 in MeOH containing 7.2 equiv of Mg(OMe) 2 (40 °C, 8 h). This furnished triol (-)-9 in 68%...
The reactivity of various 2-oxyallyl cations toward 2,2'-methylenedifuran (1b), 2,2'-(hydroxymethyl)difuran (1c), 2,2'-(trimethylsilylmethylene)difuran (1d), and di(2-furyl)methanone (1e) has been explored. Difuryl derivatives 1c, 1d, and 1e refused to undergo formal double [4+3]-cycloadditions. Conditions have been found to convert 1b into meso-1,1'-methylenedi[(1R,1'S,5S,5'R)- (3) and (+/-)-1,1'-methylenedi[(1RS,1'SR,5SR,5'RS)-8-oxabicyclo[3.2.1]oct-6-en-3-one] (4) that do not require CF(3)CH(OH)CF(3) as solvent. High yields of meso-1,1'-methylenedi[(1R,1'S,2S,2'R,4R,4'S,5S,5'R)- (5) and (+/-)-1,1'-methylenedi[(1RS,1'RS,2SR,2'SR,4RS,4'RS,5SR,5'SR)-2,4-dimethyl-8-oxabicyclo[3.2.1]oct-6-en-3-one] (6) have been obtained when 1b was reacted with 2,4-dibromopentan-3-one (7h) and NaI/Cu.
Starting from inexpensive furan and furfuryl alcohol, a noniterative approach to the synthesis of pentadeca-1,3,5,7,9,11,13,15-octols and their derivatives has been developed. The method relies upon the double [4+3]-cycloaddition of 1,1,3-trichloro-2-oxylallyl cation with 2,2'-methylenedifuran and conversion of the adducts into meso and (±)-threo-1,1'-methylenebis (cis-and trans-4,6-dihydroxycyclohept-1-ene) derivatives. The latter undergo oxidative cleavage of their alkene moieties, generating 5-hydroxy-7-oxoaldehydes that are reduced diastereoselectively into either syn or anti-5,7-diols. Asymmetry is realized using either chiral desymmetrization with Sharpless asymmetric dihydroxylation or by kinetic resolution of polyols using lipase-catalyzed acetylations. All of the possible stereomeric pentadeca-1,3,5,7,9,11,13,15-octols and derivatives can be obtained with high stereoselectivity applying simple operations, thus demonstrating the high stereodiversity of this new, noniterative approach to the asymmetric synthesis of long-chain polyketides.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.